» Download Public Reports
16 reports
- Company report
- December 2012
- 7 pages
... Thanks to the sales of newly-imported prescription drugs (including Twynsta Sales of w14.9Bn (up 51.5% Y-y)). Benefiting from these new offerings, the etc division posted 4q12 sales of w118.9Bn (up 31 ...
December 2012
... To bear fruit as several projects achieved breakthroughs during the year. We have has further strengthened our leading position in the ccv prescription drug market and become the eighth largest ...
November 2012
... Y-y -3.7 13.5 1.2 -17.3 -10.8 -11.6 -7.1 -9.5 -10.0 -1.0 Source: ubist, woori i&s research center daewoong: monthly top-10 outpatient prescription drugs (unit: wbn ...
October 2012
... Is similar to last year, but op grew 3%yoy to krw29.1Bn, which beats market expectations (krw20.9Bn) by a large margin. Even with weak prescription drug earnings following drug price cuts in apr, profitability ...
January 2012
... On domestic prescription drug sales and major players Earnings for some time. We advise investors to pay attention selectively to stocks that are less sensitive to domestic demand and poised to see tangible ...
March 2011
... Than-expected earnings thanks to strong drink product and outpatient prescription drug sales. The processed food unit saw solid sales volume growth for pre-cooked rice, trional sauces, and processed meat products ...
March 2011
... Is generally favorable to this leading general drug manufactu, although healthcare reform may be negative for manufactus of prescription drugs with high daily costs. Maintain Buy And raise tp to hk ...
» Purchase Premium Reports
(From $ 125 - $ 2 000)
40 reports
- $ 2 000
- Industry report
- April 2013
- by Asia Market Information & Development Company
China's demand for prescription drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, ...
May 2013
$ 1 088
Includes 3 FREE quarterly updates BMI View: We do not expect Taiwan's healthcare expenditure to reach the government's target of 7.5% of Gross Domestic Product in the short to medium term - unless it ...
April 2013
$ 153
CR Sanjiu Medical & Pharmaceutical Co Ltd aims to continue to establish itself as one of the leading pharmaceutical players in China over the forecast period. To realise this goal, CR Sanjiu has formed ...
March 2013
$ 125
Summary Abbott India Limited (Abbott India), a subsidiary of Abbott Laboratories, is an Indian pharmaceutical company that discovers, develops, manufactures and markets pharmaceutical, diagnostic, and ...
April 2013
$ 125
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...